Introduction
The c-Jun NH 2 -terminal kinase (JNK)/stress-activated protein kinase (SAPK) has been demonstrated to be regulated by cytokines and several cellular stresses including irradiation, alkylating agents and protein synthesis inhibitors (Kryriakis et al., 1994; Kharbanda et al., 1995; Verheij et al., 1996) . In many cell types growth factors (Kryriakis et al., 1994) and oncogenes (Roitano et al., 1995) are also capable of activating the JNK/SAPK pathway. The JNK/SAPKs are known to phosphorylate and regulate the activity of several transcription factors including ATF-2, Elk-1 and cJun (Gupta et al., 1996) . The JNK/SAPKs, like the extracellular response kinases (ERKs; p42/p44 MAPKs), are members of a sequential protein kinase pathway (Johnson and Vaillancourt, 1994) . JNK/ SAPKs are phosphorylated, resulting in their activation, by JNK kinase (JNKK/stress-activated ERK kinase or SEK-1) (Sanchez et al., 1994; Lin et al., 1995) ; JNKK/SEK-1 is itself regulated by phosphorylation by MEK kinases (MEKKs) (Lange-Carter et al., 1993; Blank et al., 1996; Gerwins et al., 1997) . The MEKK-regulated JNK/SAPK sequential protein kinase pathway is parallel to the Raf/MEK/ERK pathway and regulated in part by GTP-binding proteins including Ras, Cdc42 and Rac (Coso et al., 1995; Minden et al., 1995; Gerwins et al., 1997) .
There is increasing evidence that apoptosis in response to cellular stresses may involve signal transduction pathways that include component members of the JNK/SAPK sequential protein kinase pathways (Verheij et al., 1996; Lassignal-Johnson et al., 1996; Xia et al., 1995) . An emerging theme is that the pathways signaling apoptosis overlap with those that mediate growth and dierentiation (LassignalJohnson et al., 1996; Fanidi et al., 1992; Gardner et al., 1993; Evan et al., 1992) . In the context of signal transduction pathways, integration of signals initiated by growth factor and cytokine receptors, therefore, can commit a cell to either proliferation or apoptosis (Xia et al., 1995; Heasley et al., 1996; Gardner and Johnson, 1996) . For example, we recently demonstrated that FGF-2 protects L929 cells from TNFa-stimulated apoptosis . The protective eect of FGF-2 required functional Ras and the activation of the ERK mitogen-activated protein kinase pathway. In other studies phosphatidylinositol-3 kinase and the Akt serine/threonine protein kinase have been shown to be protective against apoptosis (Kulik et al., 1997) . The overlap of signal transduction pathways controlling growth and apoptosis probably explain, in part, why many tumors frequently express a high rate of apoptosis, but tumor cell growth is greater than apoptotic or necrotic death leading to tumor expansion (Wyllie et al., 1987) .
Cytokines such as TNFa and stresses including irradiation and chemicals that form DNA adducts induce cell death which is often associated with activation of the JNK/SAPK pathway (Kryriakis et al., 1994; Kharbanda et al., 1995; Verheij et al., 1996; Hibi et al., 1993; Haimovitz-Friedman et al., 1994; Hirano et al., 1996) . A role for the JNK/SAPK pathway in apoptosis has been proposed using inhibitory mutants of JNKK/SEK-1 to block apoptosis induced by ceramide and other stimuli (Verheij et al., 1996) . However, this fact is disputed by several other reports (Lassignal-Johnson et al., 1996; Liu et al., 1997; Jno et al., 1997). We have shown that MEKK1 can mediate apoptosis of ®broblasts in a manner that appeared largely independent of JNK/SAPK (Lassignal-Johnson et al., 1996) . Recently, MEKK1 was found to stimulate caspase activity and to be a substrate for caspase-3-like proteases (Cardone et al., 1997) . In this report, we demonstrate that low dose stress stimuli and acute expression of MEKK1 potentiate each others ability to induce apoptosis.
Results

MEKK1-mediated apoptosis
MEKK1 is a 196 kDa protein kinase. Figure 1a shows HEK293 cells stained for MEKK1 and DNA fragmentation following exposure of the cells to ultraviolet irradiation. MEKK1 staining with essentially no DNA fragmentation is seen in the control cells. After exposure to ultraviolet irradiation for 8 h HEK293 cells show signi®cant DNA fragmentation and reduced MEKK1 expression. Twenty-four hours later the cells are highly apoptotic and little MEKK1 staining is apparent, suggesting MEKK1 has been degraded. It has recently been demonstrated that MEKK1 is a substrate for caspase-3-like proteases and is cleaved at Asp 874 (Cardone et al., 1997) . Proteolytic cleavage at this site generates a COOHterminal fragment encoding the MEKK1 kinase domain. Figure 1b shows (Cardone et al., 1997) . These results demonstrate that the kinase domain of MEKK1 Quantitation of apoptotic cells 48 h later showed that 45% of MEKK1 expressing cells were TdT positive in the absence and 14% TdT positive in the presence of Z-DEVD. Two hundred cells were counted for each condition generated from the caspase-3-catalyzed cleavage, but not the full length 196 kDa MEKK1 protein, is involved in the apoptotic response. Further demonstration that caspase-3-mediated proteolysis is required for MEKK1-induced apoptosis was obtained using a caspase inhibitor. Figure 1c shows that apoptosis induced by MEKK1 is prevented by the caspase-3 inhibitor Z-DEVD.
Expression of either the wild type or DTVD?A MEKK1 mutant in HEK293 cells activated JNK activity (Figure 2 ). Since the DTVD?A MEKK1 mutant has an impaired ability to promote apoptosis, this result indicates that the JNK pathway is not sucient for the signal used by the active COOHterminal kinase domain of MEKK1 to cause apoptosis. At present, the signal pathway regulated by MEKK1 responsible for inducing apoptosis is still unclear, but the kinase activity of MEKK1 is required (LassignalJohnson et al., 1996) .
The proposal that cleavage of MEKK1 leads to apoptosis is substantiated by the ability of the MEKK1 kinase domain (DMEKK1) to induce cell death in several cell types. Expression of DMEKK1 at signi®cant levels was lethal in HEK293, T47D and MCF-7 human breast carcinoma and NRK cells as measured by colony assay following transfection (Figure 3 ). The episomal high expression plasmid, pCEP4, was used for transfection and selection of hygromycin resistant clones. It is apparent that all four cell types yield numerous hygromycin resistant clones when pCEP4 without a cDNA insert was used. In contrast, transfection of cells with pCEP4 encoding DMEKK1 results in few if any hygromycin resistant clones. It is most likely that the few remaining colonies had lost the expression of DMEKK1. Indeed, using a hemagglutinin tag-speci®c antibody, immunoblot analysis of 12 of these HEK293 hygromycin-resistant clones revealed that none expressed the tagged MEKK1 kinase domain indicating its expression had been lost during selection (not shown). A similar lethal phenotype for expression of DMEKK1 was also found in other cell types including NIH3T3 and REF52 cells (not shown). These ®ndings are characteristic for expression of DMEKK1; expression of other kinases such as activated Raf-1 actually enhance the growth of cells and enhance colony size in this assay (LassignalJohnson et al., 1996) . We have also found that expression of the kinase domain of MEKK 2 and 3 (Blank et al., 1996) does not induce apoptosis (CW, unpublished results), indicating that the apoptotic response is a speci®c and functional consequence of DMEKK1 kinase activity and is not mimicked by other MEKKs that activate the JNK pathway.
Inducible expression of DMEKK1
To further study the consequence of DMEKK1 on cellular responses to stress stimuli that can cause cell death we placed the cDNA encoding DMEKK1 under the control of the LacSwitch inducible promoter system (Stratagene, La Jolla, CA). The inducible expression resulted in a signi®cantly lower level of expression than that observed using the high expression pCEP4 plasmid. Figure 4a shows the IPTG-dependent induction of DMEKK1 in three independent Swiss 3T3 cell clones. No induction was observed in the control (LacR + ) parental cell line. IPTG-dependent expression of DMEKK1 correlated with an activation of JNK activity measured using GST-Jun as a substrate ( Figure  4b ). Fractionation of the lysates from control (LacR + ) and the MEKK1-3 clone on a MonoQ FPLC column demonstrated that the JNK activity elutes as a single early peak of activity ( Figure 4c ). This peak of activity correlated with JNK immunoreactivity (not shown). Figure 5 shows the time course of DMEKK1 protein expression and JNK activity following a single addition of IPTG to the cell culture media. Immunoreactive DMEKK1 kinase domain is detectable at four hours after addition of IPTG (Figure 5a ). JNK activity was enhanced at two hours and reached maximal activity at 12 ± 18 h after IPTG addition to the cells (Figure 5b ). The ability to detect JNK activity at an earlier time than immunoreactive MEKK1 was most likely due to the sensitivity of the two assays. The kinase assay is catalytic and ampli®es the response because the substrate, GST-Jun, is not limiting. In contrast, the immunoblot is not ampli®ed similarly and is less sensitive. Nonetheless, the time courses demonstrate that the control LacR + clone has little JNK activity in response to IPTG. The DMEKK1 clones clearly have a JNK response to exposure of the cells to IPTG that correlates with the expression of the 37 kDa catalytic domain of MEKK1.
Inducible expression of DMEKK1 potentiates cell death in response to stress and TNFa
The JNK pathway is activated in response to many cellular stresses (Kryriakis et al., 1994; Kharbanda et al., 1995; Verheij et al., 1996; Hibi et al., 1993) and the component member of the pathway, MEKK1, contributes to the decision of a cell to undergo apoptosis GST-c-Jun 1 ± 69 phosphorylation using the immunoprecipitates was performed as described in the Materials and methods (Verheij et al., 1996; Lassignal-Johnson et al., 1996; Xia et al., 1995) . Cells induced to express DMEKK1 are predicted to have an increased sensitivity to cellular stress. Figure 6 shows that cells expressing DMEKK1 were signi®cantly more sensitive to ultraviolet irradiation ( Figure 6a ) and cisplatin (Figure 6c ). At the level of DMEKK1 expression achieved with IPTG in these clones little cell death occurred over the 48 h period of the experiment. However, the cells were signi®cantly more sensitive to stress-induced death. At 10 J/M 2 ultraviolet irradiation induction of DMEKK1 caused nearly 75% of the cells to die. In contrast, the same clone without induction of DMEKK1 expression (7IPTG) had less than 10% cell death (Control, Panel A). The kinase-inactive mutant of DMEKK1 did not enhance the sensitivity to ultraviolet irradiation (Figure 6b ) or cisplatin (not shown). IPTG-treatment of control cells also did not enhance their sensitivity to ultraviolet irradiation or cisplatin (not shown). The ®ndings demonstrate that the increased sensitivity of Swiss 3T3 cells to ultraviolet irradiation and cisplatin was a result of acute DMEKK1 expression and not an eect of IPTG or dierences in Swiss 3T3 cell clones to stress-induced cell death.
L929 ®brosarcoma cells are well characterized for their TNFa-stimulated cell death response Kryprianou et al., 1991; Feshel et al., 1991) . Just as for Swiss 3T3 cells, the cDNA encoding DMEKK1 was placed under the control of the LacSwitch inducible promoter system in L929 cells. Figure 7a shows that IPTG induction of DMEKK1 expression induces JNK activity in L929 cells similar to that observed for Swiss 3T3 cells. Expression of activated MEKK1 in L929 cells potentiated the cell death response to both ultraviolet irradiation ( Figure  7b ) and TNFa (Figure 7c) . Interestingly, UVC irradiation does not signi®cantly stimulate JNK Figure 4 Inducible expression of DMEKK1. The parental LacR + and three independent DMEKK1 Swiss 3T3 cell clones were incubated for 17 h in the absence or presence of 5 mM IPTG. The LacR + clone lacks the DMEKK1 expression plasmid. Cells were lysed and immunoblotted for expression of DMEKK1 (a) or assayed for JNK/SAPK activity (b). The MEKK1-2 clone and LacR + parental clone were further characterized by fractionating the lysates by Mono Q FPLC chromatography (Gardner and Johnson, 1996) (c) . Column fractions were assayed for JNK/SAPK activity and immunoblotted with an anti-JNK1 rabbit antibody (not shown). The JNK/SAPK activity co-fractionated in the ®rst fraction after the void volume in a 0 ± 400 mM NaCl elution gradient with the JNK-1 immunoreactive protein demonstrating that inducible expression of DMEKK1 stimulates JNK1 activity activity in L929 cells, even though both TNF and DMEKK1 give a robust JNK activation. The basis for this result is unclear but must involve the loss of function or absence of a cellular component required for activating the JNK pathway in response to UVC irradiation that is independent of TNF signaling. The fact that ultraviolet irradiation induces cell death without activating JNK in L929 cells indicates that apoptosis can occur in the absence of JNK activation. Expression of DMEKK1, however, potentiates this death response; the dierence in sensitivity of Swiss 3T3 and L929 cells to ultraviolet irradiation may in part be related to the signal transduction pathways dierentially regulated in response to stress stimuli. In addition, at the level of expression achieved for DMEKK1 (K-M) the TNF stimulation of JNK activity was not inhibited. This suggests that DMEKK1 (K-M) is not a strong inhibitor of the TNF regulated pathway leading to JNK activation in L929 cells.
The death of both Swiss 3T3 and L929 cells resulting from exposure to ultraviolet irradiation involved a characteristic apoptotic response (Figure 8) . The cytoplasm and nucleus of the cells become highly condensed. An ultraviolet irradiation dose of 10 J/M 2 for Swiss 3T3 and 30 J/M 2 for L929 cells had little eect on control cell viability, the same dose caused a marked enhancement of apoptotic cells in the population when DMEKK1 expression was induced with IPTG. Over the 48 h period in which these experiments were performed the level of DMEKK1 achieved with the LacSwitch system did not induce a signi®cant death response alone.
Discussion
Our present ®ndings demonstrate that expression of DMEKK1 in dierent cell types induces a cell death Time course of IPTG-induced MEKK1 expression and JNK/SAPK activity. The LacR + parental or MEKK1-3 Swiss 3T3 cell clones were incubated in the presence of IPTG for the indicated times. Cells were lysed and immunoblotted for detection of the 37 kDa MEKK1 protein (a) or assayed for JNK/SAPK activity (b). The antisera raised against the peptide encoding the last 13 amino acids of MEKK1 was used for immunoblotting. The band seen at approximately 45 kDa is a non-speci®c protein recognized by the antisera that is lost when the antisera is anity puri®ed using a peptide anity column (Lange-Carter et al., 1993) Figure 6 Expression of DMEKK1 enhances cell death in response to ultraviolet irradiation and cisplatin. The Swiss 3T3 cell clone MEKK 1-3 having IPTG-inducible expression of DMEKK 1 (see Figures 3 and 4) was used for analysis of sensitivity to ultraviolet irradiation (UVC, 254 nm) (a) and cisplatin (c). A Swiss 3T3 cell clone having the inducible expression of a mutant kinase-inactive DMEKK1 [DMEKK1(K-M)] having the active site lysine mutated to a methionine was also used in the study (Lange-Carter et al., 1993) (b). Cells were incubated in the absence (Control) or presence (+DMEKK1) of IPTG for 17 h. Cells were then exposed to the indicated dose of ultraviolet irradiation or cisplatin for 17 h and viable cell number quantitated. Similar results were obtained with other inducible DMEKK1 clones (MEKK1-1 and MEKK1-2) (not shown). The results are representative of ®ve independent experiments. Each value is the mean of duplicate samples which varied by less than 5% response characteristic of apoptosis. Thus, the manipulation of MEKK1 activity in cells provides a novel strategy for the killing of cancer cells. In particular, if manipulation of MEKK1 activity could be used to selectively potentiate the killing of tumor cells by cytokines, irradiation or chemotherapeutic agents it may be possible to diminish the toxic eects of these treatments on non-transformed cells.
Using inducible expression of DMEKK1 we have clearly demonstrated that it is possible to potentiate the death response to TNFa, ultraviolet irradiation and cisplatin. The level of DMEKK1 expression induced in L929 or Swiss 3T3 cells for 48 h or less did not by itself cause signi®cant cell death. Expression of DMEKK1 for longer times (several days) was sucient to induce cell death (data not shown). The death response involved apoptosis in each condition we examined. Thus, by inducing the acute expression of DMEKK1 it is possible to potentiate the killing response to multiple stress stimuli that work by dierent mechanisms and pathways in tumor cells.
We propose that short term, low level activation of MEKK1`primes' cells to commit to apoptosis. The DMEKK1 potentiation of cell killing by cytokines (Kryprianou et al., 1991) , ultraviolet irradiation (Feshel et al., 1991) and cisplatin indicates that if MEKK1 activation can be targeted to tumor cells even transiently, it will be possible to develop strategies to selectively enhance cell type-speci®c apoptosis. This Cells were exposed to 30 J/M 2 ultraviolet irradiation (UVC, 254 nm) and incubated an additional 17 h. Cells were then ®xed in acetone, methanol (1:1), washed, incubated with 1 mg/ml propidium iodide, washed and examined by epi¯uorescence with a 580 nm ®lter (14). The ®elds shown are representative of three independent experiments may be accomplished, for example, by tissue speci®c promoters that express in a given tumor taking advantage of selected receptor or transcription factor overexpression or mutation to drive DMEKK1 expression. Alternatively, the MEKK1 regulatory pathway might be manipulated pharmacologically to alter the response to external stress stimuli. One strategy for this approach is to manipulate signal transduction pathways in tumor cells having autocrine/ paracrine growth factor stimulation of their proliferation to enhance the receptor stimulation of MEKK1. We have in fact, proof of concept for this approach where neuropeptides drive the proliferation of small cell lung carcinoma. It is possible to use partial agonists for speci®c neuropeptides including gastrin releasing peptide, substance P and bradykinin to activate MEKK pathways and commit small cell lung carcinoma to apoptosis (Mitchell et al., 1995) . The induction of`discordant signaling' and enhancement of MEKK1 regulated pathways in small cell lung carcinoma takes advantage of the growth factor autocrine/paracrine stimulation of tumor cell growth. By changing the balance of receptor signals that are generated and amplifying the MEKK1 response tumor cells can be made to undergo apoptosis. It is important to note that MEKK1 potentiation of apoptosis occurs in the absence of functional p53 or Rb proteins which are mutated in small cell lung carcinoma. We are currently attempting similar strategies with tumor cells expressing TGFa autocrine systems. The signi®cance of our ®ndings is that a de®ned signal transduction kinase, MEKK1, has been identi®ed for targeting new strategies to improve antitumor chemotherapy.
Materials and methods
Cell lines
Human embryonal kidney 293 cells (HEK293) stably expressing the EBNA-1 protein from Epstein ± Barr virus (Invitrogen) were grown in 10% bovine calf serum (BCS), Swiss 3T3, L929 rat ®brosarcoma and normal rat kidney (NRK) cells in 5% newborn calf/5% calf serum and MCF-7 and T47D human breast carcinoma cells in 5% fetal calf serum in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 100 U/ml penicillin/streptomycin. L929 and Swiss 3T3 cells were transfected using CaPO 4 (LassignalJohnson et al., 1996; Gardner and Johnson, 1996) with the vector 3'SS (Stratagene, La Jolla, CA) expressing the LACI repressor. Stable clones were selected in 200 mg/ml hygromycin and screened for LACI expression using indirect immuno¯uorescence with a rabbit antisera to LACI. One clone of each cell type expressing high levels of nuclear LACI were then transfected with the LACI repressible pOPRSV1 vector encoding a truncated activated form of MEKK1 (last 323 carboxy-terminal amino acids; tagged at the aminoterminus with the hemagglutinin sequence MGYPYDVP-DYAS) (Lange-Carter et al., 1993) . Stable clones were selected in 500 mg/ml G418 and screened for inducible expression of the 37 kDa truncated MEKK1 polypeptide. For Swiss 3T3 cells, ®ve inducible clones were identi®ed from 150 clones that were screened. For L929 cells, two inducible clones were isolated from G418 resistant clones. For both cell types no clones were identi®ed that had a constitutive expression of the 37 kDa MEKK1 polypeptide. MCF-7, T47D, NRK and HEK293 cells were transfected with the episomal pCEP4 expression plasmid (Stratagene, La Jolla, CA) or a pCEP4-derived plasmid (named MEKK1k.cp4) expressing the cDNA encoding the 37 kDa mouse DMEKK1. Transfection was performed with lipofectamine as follow. Cells plated at 1 ± 2610 6 per 10 cm diameter culture dishes (with cover-slips in the case of the experiment described in Figure 1 ) were cultured for 2 ± 3 days at 378C in 5% CO 2 and washed twice with 5 ml DMEM. The cells were then incubated for 5 h in a DNA/lipofectamine mixture at 378C in 5% CO 2 . Five ml of DMEM, 20% BCS, 100 U/ml penicillin G, 100 mg/ml streptomycin sulfate was then added and the cells were incubated for 16 ± 20 h at 378C, 5% CO 2 . The DNA/lipofectamine mixture was prepared by adding dropwise 600 ml of DMEM containing the DNA into 600 ml of lipofectamine solution (Gibco) (66 mg/ml in DMEM) placed in a 15 ml polypropylene tube that was shaken during the addition of the DNA. The DNA/lipofectamine mixture was incubated 30 min at room temperature before being diluted with 3.6 ml DMEM and added to the cells. pCEP4 encodes hygromycin resistance and transfected cells were isolated in 200 mg/ml hygromycin for HEK293 and T47D cells and 300 and 1500 mg/ml hygromycin for MCF-7 and NRK cells, respectively. Hygromycin-resistant cell colonies were washed with 5 ml PBS, air-dried, placed in a con®ned ethanol atmosphere for at least 20 min and incubated 5 min in ethanol. Following ethanol removal, the culture dishes were air-dried and incubated in 4 ml Giemsa stain solution (Giemsa Blood Staining Solution [Baker Inc.; Phillipsburg, NJ] diluted 1:5 in methanol) for 5 ± 30 min. The Giemsa stain was removed and the dishes were placed upside down on water for at least 20 min. The dishes were then extensively washed with water and air-dried.
JNK assay
JNK activity was measured using a solid state kinase assay using glutathione S-transferase-c-Jun (1 ± 79) (GST-Jun) bound to glutathione-Sepharose 4B beads (Hibi et al., 1993; Lassignal-Johnson et al., 1996) . Activated JNK binds to GST-Jun and is assayed in an in vitro kinase assay. Stimulated or unstimulated cells were lysed in 0.5% Nonidet P-40, 20 mM HEPES, pH 7.2, 100 mM NaCl, 2 mM dithiothreitol, 1 mM EDTA, 1.0 mM phenylmethylsulfonyl¯uoride, 1 mg/ml aprotinin and the nuclei were pelleted. Lysates were normalized for protein content and JNK activity in 50 ± 100 mg of lysate protein was bound to 10 ml of GST-Jun-glutathione-Sepharose slurry (2 mg of GST-Jun). Lysates mixed with the beads were rotated at 48C for 1 ± 3 h, washed twice in the lysis buer and then twice in PAN (10 mM PIPES, pH 7.0, 100 mM NaCl, 21 mg/ml aprotinin). Reactions were performed at 308C for 15 min in 20 mM HEPES, pH 7.2, 20 mM b-glycerophosphate, 10 mM p-nitrophenylphosphate, 10 mM MgCl 2 , 1 mM dithiothreitol, 50 mM sodium vanadate, 10 mCi [g-32 P]ATP (4 ± 5000 Ci/mmol). Reactions were linear from 0 ± 30 min.
Immunoblotting 100 mg of cell lysate was fractionated by SDS ± PAGE (12% acrylamide) and blotted to nitrocellulose in 10 mM CAPS, pH 11, 20% MeOH using a Transphor apparatus (Hoeer, San Diego, CA) for 1 h at 1A. Blots were blocked in 5% powdered milk in Tris-HCl, pH 7.5, buered saline. The 37 kDa DMEKK1 was detected using a rabbit antisera raised against a peptide encoding the last 13 amino acids of MEKK1 (Lange-Carter et al., 1993) . Blots were incubated with [ 125 I]protein A for 45 min, washed and autoradiographed.
Propidium iodide staining
Swiss 3T3 or L929 cells were plated on poly-L-lysine coated glass coverslips and grown for 24 h (Lassignal- Gardner and Johnson, 1996) . Cells were then incubated in the presence or absence of 5 mM IPTG and allowed to grow for an additional 8 h. The cells were then treated with dierent stimuli, ®xed in 3% paraformaldehyde and stained with 1 mg/ml propidium iodide. Propidium iodide¯uorescence was observed using a Nikon inverted microscope equipped with epi¯uorescence and a 580-mm ®lter. Images were analyzed using the IP Lab 3.1a software (Signal Analytical Corp.).
Fluorescence imaging of MEKK1 expression and DNA fragmentation
Cells were grown on glass coverslips and transfected using lipofectamine. Two days later the cells were ®xed with 2% paraformaldehyde, 3% sucrose in phosphate buered saline (PBS). After 10 min in ®xative, cells were washed 36 and permeabilized with 0.2% Triton X-100 in PBS. Coverslips were washed and then incubated for 15 min in tissue culture medium plus ®ltered calf serum. Subsequently, coverslips are incubated for 1 h at 378C in the terminal deoxytransferase (TdT) reaction buer (200 mM potassium cacodylate, 25 mM Tris.HCl, pH 6.6, 250 mg/ ml BSA, 5 mM CoCl 2 , 0.25 U/ml TdT, 10 mM biotin-dUTP). The cells were then washed 36 in PBS and then incubated with an anity puri®ed rabbit antisera directed at the mouse MEKK1 COOH-terminal sequence DRPPSRELLKHPVFR. Coverslips were washed 66 in PBS and then incubated with a donkey anti-rabbit, Cy 3 -conjugated, antibody mixed with 5 mg/ml streptavidin conjugated FITC. Cells on coverslips were washed 66 with PBS, incubated overnight in PBS and mounted in 20 mg/ml O-phenyldiamine-diHCl in 0.1 M Tris pH 8.5, 90% glycerol. Images were taken using a Leica DMRXA microscope and analysed with the Slidebook V2.0 software (Intelligent Imaging Innovations, Denver, CO).
The antibody used for MEKK1 expression has been characterized previously (Fanger et al., 1997) . The speci®city of the antibody for recognition of MEKK1 was veri®ed by immunoblotting and blocking of antibody staining by the peptide used for immunization. In addition, a second antibody raised against a fusion protein recognizing the MEKK1 regulatory domain gave similar staining patterns. Thus, an antisera made against a dierent MEKK1 epitope gave similar staining patterns as the COOH-terminal peptide antisera.
Ultraviolet irradiation of cells
An equilibrated shortwave UV-254 mm (UVC) mineralight lamp (model UVG-54) was used to expose cells to dierent levels of ultraviolet irradiation. The lamp was held a constant height (17 cm) above the cells in a laminar¯ow hood. Media was ®lled in the open culture dish to just cover the cells. In all experiments cells were treated with or without 5 mM IPTG for 17 h before irradiation.
MEKK1 constructs
The full length MEKK1 protein is 1463 amino acids and was expressed using the pCEP4 episomal expression plasmid. DMEKK1 in pCEP4 or the IPTG regulatable expression system encodes amino acids 1171 ± 1493. The caspase-3 three kinase domain fragment is encoded by amino acids 875 ± 1493. Expression of the COOH-terminal MEKK1 kinase domain fragment (residues 875 ± 1493) gives similar results in terms of inducing apoptosis as the DMEKK1 construct (residues 1171 ± 1493).
